Atlas Trials

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer

Clinical trial NCT00729287 · COMPLETED

Trial details

NCT number
NCT00729287
Sponsor
KU Leuven
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2009-09-01
Primary completion
2015-12-01
Enrollment
276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.